Group One Trading’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-800
Closed -$19K 8511
2025
Q4
$19K Hold
800
﹤0.01% 6371
2025
Q3
$19.9K Sell
800
-4,300
-84% -$92.5K ﹤0.01% 6699
2025
Q2
$117K Buy
5,100
+3,300
+183% +$76.4K ﹤0.01% 4840
2025
Q1
$40.4K Buy
+1,800
New +$41.8K ﹤0.01% 5320
2024
Q2
Sell
-1,100
Closed -$21.5K 7332
2024
Q1
$21.5K Buy
+1,100
New +$23.2K ﹤0.01% 5360
2023
Q1
Sell
-40,000
Closed -$908K 7797
2022
Q4
$908K Buy
40,000
+27,500
+220% +$766K ﹤0.01% 2507
2022
Q3
$426K Buy
+12,500
New +$462K ﹤0.01% 3383
2022
Q2
Sell
-1,100
Closed -$29K 8373
2022
Q1
$29K Buy
+1,100
New +$26K ﹤0.01% 6503

Other funds holding PRVA

Group One Trading's PRVA Position: Q1 2023 in Review

Group One Trading sold out of Privia Health (PRVA) in Q1 2023, closing a stake of 38,047 shares — an estimated $1M sold.

Group One Trading first reported a position in PRVA in Q4 2021 and held it in 5 quarters. The position peaked at $1.08M in Q3 2022. 191 funds tracked by Wall St. Rank hold PRVA as of Q1 2023.

  • Group One Trading reported no remaining Privia Health position as of Q1 2023 after selling out during the quarter.
  • Group One Trading sold 38,047 Privia Health shares in Q1 2023, an estimated $1M.
  • Group One Trading first reported a position in Privia Health in Q4 2021 and held it in 5 quarters.
  • Group One Trading's Privia Health position peaked at $1.08M in Q3 2022.
  • 191 funds tracked by Wall St. Rank held Privia Health as of Q1 2023.

Based on Group One Trading's 13F filing for Q1 2023, filed 12 May 2023.